rare blood coagulation disease

SK Chemicals said on Monday that it is strengthening its portfolio of neurological diseases by introducing Tiglutik (riluzole), Lou Gehrig's disease...

South Korea's Ministry of Trade, Industry and Energy said on Friday it will double the government's stockpiles of rare-earth minerals and halve thei...

Celltrion Ltd. said on Friday it had applied the previous day for permission from the US Food and Drug Administration (FDA) for Remsima SC, an autoi...

Bigsome Bio, a subsidiary of Lotte Chilsung Beverage, has begun research on functional materials for respiratory health.The company said on Friday t...

JW Pharmaceutical announced through its disclosure on Monday that it had applied last Friday for a phase 3 trial for Epaminurad, a gout treatment, w...

SK Materials Airplus Co. announced on Monday that it signed an MOU with US-based Arencibia to prepare to enter the noble gas recycling business.&n...

South Korea's GI Cell, the cell therapy affiliate of GI Innovation, on Tuesday said it signed an agreement with Optieum Biotechnologies of Japan on ...

South Korea's Medical diagnostics company Noul Co., Ltd. said on Monday that it has signed a memorandum of understanding with the Ghana Infectious D...

South Korean food giant CJ CheilJedang Corp. announced on Tuesday that it has signed a license contract with Emmyon, an American biotechnology start...

Orion Corp., the Korean company, best known for its signature product choco pie, is entering drug development. Instead of indirectly running a joint...

South Korean biopharmaceutical company Celltrion Inc. announced Friday that it won its first trial against New York-based biotech giant Regeneron Ph...

Consumption of ginseng and red ginseng (hongsam) can improve memory capacity and prevent high blood pressure, diabetes and muscle loss, according to...

Samsung Electronics Co., the world’s largest memory chipmaker, will significantly raise the use of locally produced xenon, a critical gas for ...

South Korean nonferrous metals conglomerate Poongsan Corp. announced it will invest 313 billion won ($238 million) in facilities to manufacture rech...

NEW YORK – Samsung Bioepis Co., a biopharmaceutical unit of South Korea’s top conglomerate Samsung, is one step ahead of its rivals in t...

Episodes of extreme yen weakness don’t tend to go well for Asia. In the late 1990s, early 2010s and today, a sliding yen often proves to be even...

South Korean pharmaceutical companies are jumping into the animal medicine and diagnostics market to target the rapidly growing pet care market, whi...

Samsung Bioepis Co., a biopharmaceutical unit of Samsung Group, said its SB12, a proposed biosimilar to Alexion Pharmaceuticals Inc.’s rare bl...

Dongwon Group, South Korea’s leading seafood and logistics conglomerate, is changing the merger ratio of its two major affiliates, accepting a...

The US Food and Drug Administration has begun reviewing a medicine developed by South Korea’s Hanmi Pharmaceutical Co. for marketing authoriza...

South Korea’s ABL Bio Inc. has signed a $1.06 billion contract to license out its technology for a Parkinson's disease treatment candidate t...

The South Korean government has expressed open concern about the recent request by the US Department of Commerce for more information on the global ...

South Korea’s InBody Co., the global market leader of body composition analyzer devices, will be making a strategic turn to focus on the fast-...

A number of new rare disease treatments, approved in South Korea over the past year, are still unaffordable for the public because of their price ta...

South Korea-based biopharmaceutical company TiumBio is set to acquire 30 billion won ($26 million) worth of shares in SK Plasma, a blood product com...

IMB Dx Inc., a South Korean biotechnology startup focusing on diagnostic devices, plans to develop a platform that can detect early-stage cancer wit...

South Korea’s SK Biopharmaceuticals Co. said on Friday it aspires to become one of the world’s top 10 healthcare companies by 2030 with ...

Biosimilar maker Celltrion Inc. has agreed to develop a tablet-type treatment for autoimmune diseases jointly with the UK biotech startup Intract Phar...